These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23680212)

  • 1. Tumor necrosis factor inhibition and glucose homeostasis.
    Larsen AJ; Clarke JT
    J Am Acad Dermatol; 2013 Jun; 68(6):e182-3. PubMed ID: 23680212
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous pseudolymphoma caused by tumor necrosis factor-α inhibitors was not induced by ustekinumab.
    Imafuku S; Tatsukawa R; Ito K; Nakayama J
    J Dermatol; 2012 Dec; 39(12):1070. PubMed ID: 22698067
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
    Marcella S; Welsh B; Foley P
    Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term psoriasis treatment].
    Jullien D; Battistella M
    Ann Dermatol Venereol; 2011 Feb; 138(2 Suppl 1):H15-8. PubMed ID: 21396519
    [No Abstract]   [Full Text] [Related]  

  • 5. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
    Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
    Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis.
    Koga M; Terawaki S; Tatsukawa R; Fujita M; Imafuku S; Nakayama J
    J Dermatol; 2013 Jun; 40(6):476-7. PubMed ID: 23731475
    [No Abstract]   [Full Text] [Related]  

  • 7. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
    Zschoche C; Bidier M; Hadaschik E
    J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
    Alsharqi A; Parslew R; Dever B; Arslanian V
    Australas J Dermatol; 2012 May; 53(2):e45-7. PubMed ID: 22571585
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent hyperglycemia during adalimumab treatment in a patient with psoriasis.
    Wu JJ; Tsai TF
    Arch Dermatol; 2008 Oct; 144(10):1403-4. PubMed ID: 18936418
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
    Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adalimumab].
    Aubin F; Barthelemy H
    Ann Dermatol Venereol; 2011 Dec; 138(12):842-4. PubMed ID: 22137624
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis.
    Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
    Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
    Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease.
    Jordan N; Waghmare A; Abi-Ghanem AS; Moon A; Salvatore CM
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):294-6. PubMed ID: 21694635
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterium marinum infection in a case of psoriasis treated with antitumor necrosis factor α antibody detected by QuantiFERON(®) -TB test.
    Kaneko S; Seishima M; Asano Y; Chinuki Y; Morita E
    Int J Dermatol; 2014 Mar; 53(3):e187-9. PubMed ID: 23675972
    [No Abstract]   [Full Text] [Related]  

  • 16. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis.
    Dicaro D; Bowen C; Dalton SR
    J Am Acad Dermatol; 2014 Mar; 70(3):e64-5. PubMed ID: 24528921
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis.
    Avgerinou G; Tousoulis D; Siasos G; Oikonomou E; Maniatis K; Papageorgiou N; Paraskevopoulos T; Miliou A; Koumaki D; Latsios G; Therianiou A; Trikas A; Kampoli AM; Stefanadis C
    Int J Cardiol; 2011 Sep; 151(3):382-3. PubMed ID: 21764467
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy during adalimumab use for psoriasis.
    Dessinioti C; Stefanaki I; Stratigos AJ; Kostaki M; Katsambas A; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):738-9. PubMed ID: 20569288
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy.
    Hay RA; Pan JY
    Clin Exp Dermatol; 2014 Aug; 39(6):751-2. PubMed ID: 24984757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.